Antibody positron emission tomography imaging in anticancer drug development

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Laetitia E LambertsElisabeth G E de Vries

Abstract

More than 50 monoclonal antibodies (mAbs), including several antibody-drug conjugates, are in advanced clinical development, forming an important part of the many molecularly targeted anticancer therapeutics currently in development. Drug development is a relatively slow and expensive process, limiting the number of drugs that can be brought into late-stage trials. Development decisions could benefit from quantitative biomarkers, enabling visualization of the tissue distribution of (potentially modified) therapeutic mAbs to confirm effective whole-body target expression, engagement, and modulation and to evaluate heterogeneity across lesions and patients. Such biomarkers may be realized with positron emission tomography imaging of radioactively labeled antibodies, a process called immunoPET. This approach could potentially increase the power and value of early trials by improving patient selection, optimizing dose and schedule, and rationalizing observed drug responses. In this review, we summarize the available literature and the status of clinical trials regarding the potential of immunoPET during early anticancer drug development.

References

May 6, 1983·Science·D J HnatowichP W Doherty
Jan 31, 2002·Annual Review of Medicine·Johannes Czernin, Michael E Phelps
Oct 3, 2002·Journal of the National Cancer Institute·Gordon C JaysonUNKNOWN European Organisation for Research and Treatment of Cancer Biological Therapeutic Development Group
May 4, 2005·Cancer Chemotherapy and Pharmacology·Rene BrunoPamela Klein
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick J PerikElisabeth G E de Vries
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Apr 14, 2007·Nature Reviews. Drug Discovery·Janice M Reichert, Viia E Valge-Archer
May 1, 2007·World Journal of Gastroenterology : WJG·Yun-Feng YaoJin Gu
Jan 15, 2008·Drug Discovery Today·Janice M Reichert, Julia B Wenger
Apr 4, 2008·Nature·Charles L Sawyers
Apr 4, 2008·Nature·Ralph Weissleder, Mikael J Pittet
Jun 10, 2008·The Cancer Journal·Anna M Wu, Tove Olafsen
Jul 2, 2008·Nature Reviews. Drug Discovery·Jürgen K WillmannSanjiv S Gambhir
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John V Frangioni
Dec 19, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hugo J W L AertsPhilippe Lambin
Jan 8, 2009·Bioconjugate Chemistry·Tapan K Nayak, Martin W Brechbiel
Feb 19, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Robert M SharkeyDavid M Goldenberg
Jun 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gang NiuXiaoyuan Chen
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Khaled M MusallamAli I Shamseddine
Oct 15, 2009·The Cancer Journal·Daniel S W TanPaul Workman
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Pontus K E BörjessonRonald Boellaard
Feb 2, 2010·Seminars in Nuclear Medicine·Stanley J Goldsmith
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gang NiuXiaoyuan Chen
Apr 17, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wouter B NagengastElisabeth G E de Vries
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thijs H Oude MunninkElisabeth G de Vries
May 21, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Tapan K NayakMartin W Brechbiel
Jul 9, 2010·Clinical Pharmacokinetics·Ron J KeizerJos H Beijnen
Aug 17, 2010·Cancer Biotherapy & Radiopharmaceuticals·Guus A M S van Dongen, Maria J W D Vosjan
Oct 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ingrid M E DesarWim J G Oyen
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 25, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wouter B NagengastGeke A P Hospers
Apr 12, 2011·International Journal of Radiation Oncology, Biology, Physics·William W WongMichael C Roarke
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jul 19, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jorge A CarrasquilloSteven M Larson
Oct 13, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Anton G T Terwisscha van ScheltingaElisabeth G E de Vries

❮ Previous
Next ❯

Citations

May 4, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A K L ReynersM Jalving
Feb 14, 2016·American Journal of Hematology·Antoinette de JongBart de Keizer
Aug 20, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Françoise Kraeber-BodereJean-François Chatal
Jul 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elisabeth G E de VriesJourik A Gietema
Mar 8, 2016·Biomarkers in Cancer·Rosalyn A JuergensKaren Y Gulenchyn
Jul 11, 2018·Future Oncology·Francesco PassigliaRaffaele Conca
Oct 15, 2018·Journal of Cellular Physiology·Hamid Reza MirzaeiJamshid Hadjati
Nov 28, 2018·Nature Reviews. Clinical Oncology·Elisabeth G E de VriesSjoukje F Oosting
Nov 21, 2018·The Journal of Clinical Investigation·Dhiraj KumarSridhar Nimmagadda
Jan 23, 2018·EJNMMI Research·Yvonne W S JauwC Willemien Menke-van der Houven van Oordt
Jun 13, 2019·Lab on a Chip·Jia WangR Michael van Dam
Feb 12, 2020·Drug Metabolism Reviews·Hanlan LiuChandra Prakash
Mar 31, 2016·Oncotarget·Simon-Peter WilliamsAnton G T Terwisscha van Scheltinga
Jan 9, 2019·Frontiers in Pharmacology·Guozheng Liu
Apr 13, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Weijun WeiWeibo Cai
Jun 25, 2020·EJNMMI Radiopharmacy and Chemistry·Javad GarousiVladimir Tolmachev
May 2, 2018·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Yvonne W S JauwMarc C Huisman
Jun 19, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Yvonne W S JauwMarc C Huisman
Sep 5, 2019·Cancers·Clément BaillyThomas Carlier
Mar 15, 2020·Cancers·Vladimir Tolmachev, Anna Orlova
Oct 7, 2020·Journal for Immunotherapy of Cancer·Elly L van der VeenMarjolijn N Lub-de Hooge
Jan 26, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laetitia E LambertsGooitzen M van Dam
Jan 26, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guolan LuEben L Rosenthal
Feb 7, 2020·Molecular Cancer Therapeutics·Lidia NazarovaC Andrew Boswell
Nov 22, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laetitia E LambertsElisabeth G E de Vries
Jul 25, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Frederike BenschElisabeth G E de Vries
Oct 21, 2016·Molecular Cancer Therapeutics·Anton G T Terwisscha van ScheltingaSimon-Peter Williams
Dec 4, 2020·Journal for Immunotherapy of Cancer·Siwen Hu-LieskovanHolden T Maecker
May 6, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Raymond M Reilly
Mar 17, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ahmet KrasniqiVladimir Tolmachev
Jan 30, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martin PoolElisabeth G E de Vries
May 8, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ohad IlovichDaniel P Bradley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Howard I ScherRichard Simon
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
W A Weber
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Jai N PatelHoward L McLeod
© 2021 Meta ULC. All rights reserved